Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

Speaking of cancer and companies trying to save lives,...

God bless all the young ones battling cancer. Here's a cool 2106 Christmas story from Owings Mills, MD - "Young Boy With Cancer Transformed Into Super Hero. http://baltimore.cbslocal.com/2016/12/17/young-boy-with-cancer-transformed-into-super-hero/

Cellceutix's Kevetrin drug received Rare Pediatric Disease Designation from the FDA for Orphan Drug treatment of retinoblastoma, a rare type of eye cancer that originates in the retina. The big benefit of the designation is the opportunity to apply for a Rare Pediatric Disease Review Voucher, which can be used for Priority Review (six months) of a future NDA or can be sold to a third party. The vouchers are quite valuable. In 2014, AbbVie bought one from United Therapeutics for $350M in cash. Yet another opportunity for Cellceutix to save young ones battling cancer.